A detailed history of Five Oceans Advisors transactions in Pfizer Inc stock. As of the latest transaction made, Five Oceans Advisors holds 10,097 shares of PFE stock, worth $266,863. This represents 0.15% of its overall portfolio holdings.

Number of Shares
10,097
Previous 7,432 35.86%
Holding current value
$266,863
Previous $207,000 41.06%
% of portfolio
0.15%
Previous 0.12%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 15, 2024

BUY
$27.7 - $31.39 $73,820 - $83,654
2,665 Added 35.86%
10,097 $292,000
Q2 2024

Jul 10, 2024

SELL
$25.26 - $29.6 $95,280 - $111,651
-3,772 Reduced 33.67%
7,432 $207,000
Q1 2024

Apr 16, 2024

BUY
$25.89 - $29.73 $17,501 - $20,097
676 Added 6.42%
11,204 $310,000
Q4 2023

Jan 22, 2024

SELL
$26.13 - $33.94 $18,656 - $24,233
-714 Reduced 6.35%
10,528 $303,000
Q3 2023

Oct 17, 2023

SELL
$32.09 - $37.51 $4,556 - $5,326
-142 Reduced 1.25%
11,242 $372,000
Q2 2023

Jul 14, 2023

BUY
$36.12 - $41.79 $49,376 - $57,126
1,367 Added 13.65%
11,384 $417,000
Q1 2023

Apr 14, 2023

BUY
$39.39 - $51.28 $97,805 - $127,328
2,483 Added 32.96%
10,017 $408,000
Q4 2022

Jan 17, 2023

BUY
$41.75 - $54.5 $7,055 - $9,210
169 Added 2.29%
7,534 $0
Q3 2022

Nov 02, 2022

SELL
$43.76 - $53.42 $11,027 - $13,461
-252 Reduced 3.31%
7,365 $322,000
Q2 2022

Jul 15, 2022

BUY
$46.53 - $55.17 $15,866 - $18,812
341 Added 4.69%
7,617 $399,000
Q1 2022

Apr 19, 2022

SELL
$45.75 - $56.69 $7,731 - $9,580
-169 Reduced 2.27%
7,276 $377,000
Q4 2021

Jan 14, 2022

BUY
$41.32 - $61.25 $9,544 - $14,148
231 Added 3.2%
7,445 $440,000
Q3 2021

Oct 13, 2021

BUY
$39.25 - $50.42 $283,149 - $363,729
7,214 New
7,214 $310,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $148B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Five Oceans Advisors Portfolio

Follow Five Oceans Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Five Oceans Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Five Oceans Advisors with notifications on news.